Flourtown, PA, United States of America

Dennis T Takata

This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dennis T Takata. Retrieved from https://idiyas.com/inventor/dennis-t-takata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dennis T Takata

Introduction

Dennis T Takata is a notable inventor based in Flourtown, Pennsylvania. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on benzimidazoles and imidazoles.

Latest Patents

Dennis holds a patent for "Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist." This invention showcases his expertise in developing compounds that can potentially impact medical treatments.

Career Highlights

Throughout his career, Dennis has been associated with SmithKline Beecham Corporation, where he has contributed to various research initiatives. His work has been instrumental in advancing pharmaceutical science.

Collaborations

Dennis has collaborated with notable colleagues, including Fadia E Ali and William Edward Bondinell. These partnerships have fostered a collaborative environment that enhances innovation.

Conclusion

Dennis T Takata's contributions to the field of pharmaceuticals through his patent and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…